Science & medicine news
-
Catherine Corbin named chief business innovation officer at St. Jude
Expert in human-centered design to lead new St. Jude department focused on advancing strategic plan.
-
St. Jude names leading researcher as new chair of oncology department
Julie R. Park, M.D., to succeed longtime chair Ching-Hon Pui, M.D.
-
Pioneering approach advances study of CTCF protein in transcription biology
Scientists at St. Jude used an innovative degradation system on CTCF, learning more about this protein’s role in transcription. Read about the findings.
-
St. Jude Children’s Research Hospital unveils 45,000-square-foot Family Commons
Made possible by a $50 million donation from AbbVie, Family Commons is a space for patients and their families to relax and gather in between clinic appointments.
-
Structural insights reveal how SPOP protein contributes to cancer
St. Jude scientists have captured the 3D structure of the SPOP protein, revealing how it contributes to cancer. Read about the implications for therapeutics.
-
Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’
St. Jude scientists performed the largest study yet examining drug sensitivity in childhood acute lymphoblastic leukemia across genomic subtypes and its association with treatment response.